BENDER ROBERT & ASSOCIATES Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0000894300

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedTechnology TiltHigh Turnover how tags are computed

Q2 2026 · 39 positions · Total reported value $481.20M · Top-10 concentration 74.4% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 49.0% · 10 new · 11 cut · 3 exited

Active Share (vs S&P 500): 63.1% · vs QQQ: 59.6% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, BENDER ROBERT & ASSOCIATES disclosed 39 equity positions with a combined reported value of $481.20M. The filing implies a focused portfolio: its ten largest positions account for 74.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were NVDA ($87.29M), AAPL ($74.41M), AMD ($35.10M). By sector, the heaviest allocations are Technology 64.4%, Consumer Discretionary 17.4%. Versus the prior quarter, allocation shifted toward Technology (+4.4pp) and away from Health Care (-1.6pp), Consumer Discretionary (-2.5pp).

Versus the prior quarter, BENDER ROBERT & ASSOCIATES opened 10 new positions, trimmed 11 and fully exited 3, a turnover rate of 49.0% of positions. The portfolio's overlap with the prior quarter was 83% of names.

The largest new positions opened in Q2 2026 were INTC ($234.62K).

Of the 3 positions fully exited versus the prior quarter, the largest were URGN ($623.92K), PLSE ($263.18K), V ($261.21K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • INTC INTEL CORP · $234.62K

Fully Exited (vs previous quarter)

  • URGN UROGEN PHARMA LTD · prev qtr: $623.92K · history
  • PLSE PULSE BIOSCIENCES INC · prev qtr: $263.18K · history
  • V VISA INC · prev qtr: $261.21K · history
  • AEP AMERICAN ELEC PWR CO INC · prev qtr: $249.05K · history
  • BCRX BIOCRYST PHARMACEUTICALS INC · prev qtr: $225.72K · history
  • MAR MARRIOTT INTL INC NEW · prev qtr: $219.79K · history
  • EOLS EVOLUS INC · prev qtr: $103.04K · history

Insider Transactions (Form 4)

Latest BENDER ROBERT & ASSOCIATES buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Bender Robert & Associates is an SEC-registered 13F filer. As of Q2 2026 it reported 39 US equity positions with a combined value of $481.20M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 39 positions · $481.20M reported value (Q2 2026)
  • Top 10 holdings = 74.4% of reported value
  • Largest position: NVDA (NVIDIA CORPORATION) at 18.1%
  • Average position size: $12.34M

Sector Tilt

  • Information Technology 64.4%
  • Consumer Discretionary 17.4%
  • Health Care 14.8%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 10 added, 12 reduced, 7 exited
  • 16 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to be taking a cautious approach with a slight preference for Technology and Health Care sectors. The reduction in positions across multiple Technology stocks suggests a concern over valuation or market conditions, while the addition to Eli Lilly & Co. indicates a belief in the pharmaceutical sector's potential. 2. Key Moves: - Reduced Positions: The fund reduced its holdings in NVIDIA Corporation, Apple Inc., Advanced Micro Devices Inc., Alphabet Inc., and Meta Platforms Inc. The largest reduction was in NVIDIA, followed by Apple and AMD. - Added Position: Eli Lilly & Co. was added to the portfolio, with a minor increase in shares. - Hold Positions: Amazon.com Inc., Intuitive Surgical Inc., MercadoLibre Inc., and Alphabet Inc. (GOOGL) were held steady. 3. Portfolio Structure: - Passive/Active: The fund's rebalancing seems more active, with deliberate adjustments to the existing holdings rather than a passive indexing strategy. - Sector Bias: The portfolio has a strong bias towards Technology, which accounts for over 40% of the total value, followed by Consumer Discretionary and Health Care. - Risk Appetite: The risk appetite seems moderate, with a preference for established companies in Technology and Health Care sectors, rather than high-growth or speculative stocks. 4. Per-Holding One-Liner: - NVDA: NVIDIA Corporation (NVIDIA) - Designs graphics processing units (GPUs) for the gaming, professional visualization, and data center markets. - AAPL: Apple Inc. (AAPL) - Designs, manufactures, and markets consumer electronics, software, and services. - AMD: Advanced Micro Devices Inc. (AMD) - Develops and supplies high-performance computing and graphics processing units. - AMZN: Amazon.com Inc. (AMZN) - Operates an online marketplace for consumers, sellers, and content creators. - ISRG: Intuitive Surgical Inc. (ISRG) - Develops, manufactures, and markets robotic systems for minimally invasive surgery. - GOOG: Alphabet Inc. (GOOG) - Parent company of Google, providing internet-related services and products. - LLY: Eli Lilly & Co. (LLY) - Develops and manufactures pharmaceutical products. - META: Meta Platforms Inc. (META) - Operates social media platforms including Facebook, Instagram, and WhatsApp. - MELI: MercadoLibre Inc. (MELI) - Operates an e-commerce and payments platform in Latin America. - GOOGL: Alphabet Inc. (GOOGL) - Same as GOOG, but the Class A shares are listed on the NASDAQ. 5. One-Sentence Style Summary: The fund is rebalancing with a cautious approach, trimming Technology holdings and adding to pharmaceuticals, reflecting a preference for established companies in stable sectors.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Technology 64.4%
Health Care 14.8%
Financials 2.4%
Utilities 0.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 436.25K $87.29M 18.14%
18.14%
Reduce
2 257.17K $74.41M 15.46%
15.46%
Reduce
3 60.42K $35.10M 7.29%
7.29%
Reduce
4 126.38K $30.12M 6.26%
6.26%
Hold
5 68.65K $27.30M 5.67%
5.67%
Hold
6 64.31K $22.72M 4.72%
4.72%
Reduce
7 17.64K $21.16M 4.40%
4.40%
Add
8 36.17K $20.38M 4.23%
4.23%
Reduce
9 11.67K $19.82M 4.12%
4.12%
Hold
10 54.53K $19.49M 4.05%
4.05%
Hold
11 55.59K $18.96M 3.94%
3.94%
Add
12 26.30K $13.07M 2.71%
2.71%
Add
13 10.58K $12.43M 2.58%
2.58%
Add
14 31.05K $10.58M 2.20%
2.20%
Hold
15 21.10K $9.52M 1.98%
1.98%
Hold
16 44.51K $7.93M 1.65%
1.65%
Add
17 19.96K $7.45M 1.55%
1.55%
Add
18 39.26K $6.90M 1.44%
1.44%
Hold
19 62.72K $6.23M 1.29%
1.29%
Add
20 22.76K $4.67M 0.97%
0.97%
Reduce
21 40.18K $4.59M 0.95%
0.95%
Reduce
22 44.26K $4.52M 0.94%
0.94%
Add
23 8.79K $3.10M 0.64%
0.64%
Add
24 34.69K $3.04M 0.63%
0.63%
Add
25 29.36K $2.83M 0.59%
0.59%
Hold
26 1.27K $1.19M 0.25%
0.25%
Reduce
27 916 $975.45K 0.20%
0.20%
Reduce
28 3.22K $818.80K 0.17%
0.17%
Hold
29 2.48K $812.01K 0.17%
0.17%
Reduce
30 2.39K $602.17K 0.12%
0.12%
Hold
31 912 $578.51K 0.12%
0.12%
Hold
32 4.04K $519.38K 0.11%
0.11%
Reduce
33 2.27K $506.76K 0.10%
0.10%
Hold
34 2.82K $356.15K 0.07%
0.07%
Hold
35 2.05K $300.72K 0.06%
0.06%
Hold
36 2.90K $263.60K 0.06%
0.06%
Hold
37 622 $234.96K 0.05%
0.05%
Reduce
38 1.68K $234.62K 0.05%
0.05%
New
39 1.75K $221.26K 0.05%
0.05%
Hold

FAQ

What did BENDER ROBERT & ASSOCIATES buy in 2026-Q2?

In its 2026-Q2 13F filing, BENDER ROBERT & ASSOCIATES reported 39 equity positions worth $481.20M in aggregate; its largest disclosed positions were NVDA ($87.29M), AAPL ($74.41M), AMD ($35.10M).

How large is BENDER ROBERT & ASSOCIATES's portfolio?

BENDER ROBERT & ASSOCIATES reported $481.20M of long equity holdings across 39 positions as of 2026-Q2. Top-10 holdings account for 74.4% of reported value.

What is BENDER ROBERT & ASSOCIATES's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bender-robert-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →